Lataa...
Methylene blue treatment in experimental ischemic stroke: A mini-review
Stroke is among the leading causes of death and long-term disability. Methylene blue (MB), a drug grandfathered by the Food and Drug Administration with a long history of safe usage in humans for treating methemoglobinemia and cyanide poisoning, has recently been shown to be neuroprotective in neuro...
Tallennettuna:
| Julkaisussa: | Brain Circ |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medknow Publications & Media Pvt Ltd
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4817094/ https://ncbi.nlm.nih.gov/pubmed/27042692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2394-8108.178548 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|